CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 179 enrolled
Drug / intervention
Mobile Diabetes Prevention Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05856149
NCT05856149N/ACompleted

Diabetes Prevention for Hispanics Residing in Rural Communities: A Mobile Web-Based Approach

ISA Associates, Inc.·interventional·Posted May 12, 2023·Updated Feb 23, 2026

In Brief

A clinical study evaluating Mobile Diabetes Prevention Program for Type 2 Diabetes. Completed, enrolled 179 participants across 1 site.

Detailed Summary

The goal of this Randomized Controlled Trial (RCT) is to test the effectiveness of a mobile, web-based diabetes prevention program for Hispanics living in rural communities. The main question it aims to answer is: Does STEPS, a mobile, web-based diabetes prevention program, reduce the risk of Type II Diabetes in rural Hispanics compared to usual care? Participants will be randomly assigned to receive either the mobile STEPS intervention or usual care for a total of three months. Researchers will compare percentage weight loss, and additional outcome measures in participants of both groups at months three and six post-baseline.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedMay 12, 2023
Enrollment StartApr 19, 2023
Primary CompletionNov 1, 2024
Study CompletionJan 31, 2025
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 3.1 years ago

Interventions

Mobile Diabetes Prevention Programbehavioral

The intervention is a mobile, web-based diabetes prevention program that participants will have access to for a total of 12 weeks. The intervention is a behavioral intervention aimed at increasing the knowledge and skills of participants to reduce type 2 diabetes risk behaviors.